Phibro Animal Health Corporation PAHC

34.45 0.52 1.53% as of 25 Sep
Market cap
$1.4B
P/E
14.0×
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20 Jun '19 Jun '18 Jun '17
P/E ratio
12.76 21.46 284.00 16.91 15.81 21.55 32.04 23.25 29.10 22.59
P/S ratio
0.84 0.80 0.68 0.57 0.82 1.40 1.33 1.54 2.30 1.92
P/FCF ratio
129.04 24.74 14.89 0.00 0.00 61.56 42.00 73.96 36.58 18.89
P/Operating CF
52.84 48.64 24.28 27.42 492.28 380.74 274.11 85.88 186.22 107.87
P/B ratio
3.30 3.62 2.69 1.96 2.95 4.90 5.65 5.92 10.18 9.69
Price to Tangible BV
4.31 5.46 4.39 3.18 5.33 9.46 16.47 9.05 17.82 20.18
EV/Sales
1.27 1.29 1.05 0.97 1.18 1.76 1.70 1.84 2.58 2.25
EV/EBITDA
7.75 10.60 11.75 8.90 9.94 13.64 13.26 13.63 16.69 13.78
EV/Operating CF
27.90 20.92 12.14 71.26 35.28 30.38 22.89 32.28 30.22 17.50
EV/FCF
195.01 40.08 22.95 (24.65) (206.95) 77.31 53.69 88.11 41.11 22.21
Quick Ratio
1.01 1.04 1.39 1.39 1.35 1.46 1.39 1.56 1.50 1.57
Current Ratio
2.96 2.76 2.94 3.33 2.97 3.04 2.87 3.02 2.90 3.14
Net Debt/EBITDA
2.62 4.06 4.13 3.69 3.04 2.78 2.89 2.19 1.84 2.06
Debt/Assets
48.81% 52.81% 49.69% 48.88% 46.47% 46.60% 49.36% 44.89% 46.51% 50.23%
Debt/Equity
1.90 2.52 1.90 1.68 1.65 1.64 2.06 1.51 1.69 2.07
Asset Turnover
1.06 1.11 1.04 1.03 1.06 1.03 1.06 1.18 1.27 1.24
Operating CF/Net income
0.69 1.66 36.26 0.41 0.64 0.89 1.77 0.86 1.08 1.52
Capex/Depreciation
(1.10) (0.80) (1.11) (1.49) (1.11) (0.90) (1.02) (1.05) (0.67) (0.77)
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
29.72% 17.80% 0.90% 11.97% 19.63% 25.49% 16.60% 27.29% 38.61% 53.48%
ROA
6.97% 4.12% 0.25% 3.43% 5.55% 6.69% 4.44% 7.83% 10.02% 10.50%
ROIC
11.72% 7.45% 5.29% 6.64% 8.17% 8.71% 8.94% 11.29% 14.79% 14.99%
Return on Tangible Assets
10.09% 5.54% 0.40% 5.39% 9.09% 11.11% 7.58% 12.10% 16.13% 17.22%
Average Days of Receivables
57.41 64.20 60.78 61.02 64.51 64.32 57.70 70.10 60.42 60.10
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
20.96% 22.33% 25.53% 23.15% 21.91% 23.58% 23.45% 21.91% 20.48% 19.67%
Intangible Assets out of Total Assets
0.06 0.07 0.10 0.11 0.13 0.14 0.16 0.10 0.12 0.13
Share Based Compensation of Revenue
0.11% 0.06% 0.05% 0.00% 0.00% 0.14% 0.28% 0.27% 0.04% 0.00%
Graham Net Nets
(0.14) (0.26) (0.18) (0.19) (0.13) (0.09) (0.14) (0.03) (0.04) (0.07)
Graham Number
22.94 13.74 2.92 11.27 13.28 13.33 9.26 12.79 12.91 11.88
Earnings Yield
7.83% 4.66% 0.35% 5.91% 6.33% 4.64% 3.12% 4.30% 3.44% 4.43%
Free Cash Flow Yield
0.77% 4.04% 6.72% (6.94%) (0.70%) 1.62% 2.38% 1.35% 2.73% 5.29%
Revenue per Share
37.44 31.99 25.13 24.14 23.26 20.59 19.78 20.49 20.41 19.34
Operating CF per Share
1.70 1.98 2.16 0.33 0.78 1.19 1.47 1.17 1.74 2.49
Capex per Share
(1.46) (0.95) (1.02) (1.28) (0.91) (0.72) (0.84) (0.74) (0.46) (0.53)
Free Cash Flow per Share
0.24 1.03 1.14 (0.95) (0.13) 0.47 0.63 0.43 1.28 1.96
Cash per Share
2.02 1.90 2.83 2.01 2.25 2.30 2.26 2.02 1.97 1.42
Shareholders Equity per Share
9.51 7.05 6.34 6.97 6.48 5.89 4.65 5.35 4.60 3.82
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
9.51 7.05 6.34 6.97 6.48 5.89 4.65 5.35 4.60 3.82
Free Cash Flow
9.87 41.83 46.36 (38.48) (5.39) 18.99 25.30 17.28 51.46 77.51
Working Capital
619.04 517.13 396.85 409.72 375.40 334.79 294.60 311.94 272.24 247.87
Capital Expenditures
(59.09) (38.29) (41.24) (51.79) (37.04) (29.32) (34.04) (29.89) (18.55) (20.88)
Net Current Asset Value
(180.26) (264.61) (124.55) (103.16) (103.02) (103.89) (144.06) (44.49) (71.26) (108.57)
EV/EBIT
9.90 15.18 19.95 13.20 14.14 19.60 19.63 18.29 21.39 17.58
Capex to Sales
0.04 0.03 0.04 0.05 0.04 0.04 0.04 0.04 0.02 0.03
Net Profit Margin
6.57% 3.72% 0.24% 3.33% 5.22% 6.53% 4.19% 6.61% 7.91% 8.45%
Price to Operating Income
6.55 9.37 12.95 7.72 9.81 15.61 15.36 15.35 19.03 14.95
Other line items
Depreciation/Fixed assets
0.15 0.13 0.18 0.18 0.20 0.21 0.22 0.20 0.21 0.21
Cash ROIC
(25.01%) (25.39%) (13.46%) (21.73%) (17.01%) (14.70%) (13.32%) (14.92%) (10.42%) (5.57%)
Accounts Receivable Turnover
6.50 6.52 6.11 5.93 6.01 6.10 5.61 5.62 6.27 6.12
Accounts Payable Turnover
7.57 8.01 8.84 8.02 8.01 8.36 7.80 8.49 9.50 8.82
Inventory Turnover
2.05 2.52 2.59 2.53 2.76 2.72 2.75 2.99 3.26 3.14
Average Days of Payables
46.21 56.28 44.33 39.66 53.12 44.40 44.39 47.42 39.26 40.24
Days of Inventory on Hand
194.15 180.99 137.75 149.07 144.01 140.49 132.08 128.49 117.58 114.04
Average Receivables
233.39 198.72 166.47 165.01 156.69 136.69 142.77 147.38 130.79 124.82
Average Payables
132.76 111.88 79.71 84.72 81.98 67.23 69.64 66.34 58.20 58.53
Average Inventory
489.65 355.17 271.74 268.36 237.74 206.49 197.49 188.25 169.70 164.46
Average Assets
1,431.07 1,171.54 976.79 951.55 886.51 812.71 755.39 699.18 647.54 615.62
Average Common Equity
335.58 271.16 269.58 272.48 250.49 213.37 202.11 200.48 168.06 120.82

Fold the line items

Columns are period end dates